NCT06391879View on ClinicalTrials.gov

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
VHL SyndromeRenal Cell Carcinoma
Interventions
GENETIC

Single cell sequencing, whole genome and metabolomic sequencing

The blood specimen of subjects in this cohort would be collected to conduct single cell sequencing, whole genome and metabolomic sequencing.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER